Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04414540
Title Combining Pembrolizumab and Metformin in Metastatic Head and Neck Cancer Patients
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Trisha Wise-Draper
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Cincinnati Medical Center Cincinnati Ohio 45219 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field